MediWound (NASDAQ:MDWD) Announces Quarterly Earnings Results

MediWound (NASDAQ:MDWD – Get Rating) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.15) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.15), MarketWatch Earnings reports. MediWound had a negative return on equity of 332.31% and a negative net margin of 44.58%. During the same quarter last year, the […]

Related Keywords

Yavne ,Hamerkaz ,Israel ,Lior Rosenberg ,Thomson Reuter ,Marian Gorecki ,Morgan Stanley ,Mediwound Company Profile Get Rating ,Wells Fargo Company ,Goldman Sachs Group Inc ,Zacks Investment Research ,Millennium Management ,Mediwound Ltd ,Get Rating ,Marketwatch Earnings ,Investment Research ,Street Group ,Sachs Group ,Wells Fargo ,Wound Company Profile ,Mediwound ,Nasdaq Mdwd ,Mdwd ,Medical ,Earnings ,